Lead Product(s) : Alanyl Glutamine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase IV
Sponsor : Swiss National Science Foundation | Fresenius Kabi AB Brunna | University Hospital Zürich
Deal Size : Inapplicable
Deal Type : Inapplicable
Optimized Therapy in Severe Traumatic Brain Injured Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Peptide
Upfront Cash : Inapplicable
May 05, 2014
Lead Product(s) : Alanyl Glutamine
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase IV
Sponsor : Swiss National Science Foundation | Fresenius Kabi AB Brunna | University Hospital Zürich
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Alanyl Glutamine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Kyowa Hakko Bio
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Sustamine(TM) on Cycling Time Trial Performance
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 20, 2012
Lead Product(s) : Alanyl Glutamine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Kyowa Hakko Bio
Deal Size : Inapplicable
Deal Type : Inapplicable